Sarah Pringle

Comar, now generating over $200m in revenue, will target select M&A opportunities within the scientific molding, micromolding, silicon and sharps areas.

PRN's Houlihan Lokey-run auction gets underway as Gryphon Investors gears up to sell the even-larger Cora Physical Therapy.

Pharmacy company ExactCare hits the block.

Nautic in March 2016 recapitalized ExactCare, which specializes in serving complex patients in their homes.

The Boca Raton, Florida, firm eyes potential opportunities for investment in eyecare, behavioral health and across the orthopedic supply chain.

In healthcare, private equity firms are buzzing around the primary care vertical.

The Florida provider of at-risk primary care for seniors has grown from one to 35 clinics in three years.

PPD's value has grown more than 288 percent since H&F and Carlyle backed the company in December 2011, with its IPO assigning it an initial enterprise value of ~$14bn.

Pharmaceutical Product Development goes public eight years after H&F and Carlyle completed its buyout.

Current healthcare efforts are being led by members that include Greg Brenneman, Richard Zannino, Kevin O’Brien and Shane McHugh.